Skip to content

Author

Jung Tak Park

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Plasma Levels of Growth Differentiation Factor 15 and Adverse Kidney Outcomes: Proteomics-Based Mediation Analysis and Mendelian Randomization.

BACKGROUND Growth differentiation factor-15 (GDF-15) has been implicated in adverse outcomes in cardiovascular disease and diabetes, highlighting its potential as a prognostic marker. However, its association with chronic kidney disease (CKD) development remains unclear. Therefore, we investigated the association betwe...

Hee Byung Koh, Hyo Jeong Kim, Seok-Jae Heo et al. · 0 citations
Open access Oct 2026

The effect of the interplay between PGC-1α and HIF-1α on preserving mitochondrial metabolism in diabetic kidney disease.

Background Hypoxia-inducible factor-1 alpha (HIF-1α) plays a multifaceted role in energy metabolism by promoting glycolysis and inhibiting pyruvate kinase M2 (PKM2) activity. This study aimed to investigate the role of peroxisome proliferator-activated receptor- gamma coactivator-1 alpha (PGC-1α) in modulating HIF-1α-m...

Jee-Young Lee, B. Nam, Jaejin Ryu et al. · 0 citations
Aug 2026

Proteinuria and Kidney Function Trajectories in Patients with Advanced CKD: Insights from CRIC and KNOW-CKD Studies.

Higher UPCR levels were strongly associated with accelerated CKD progression and shorter projected time to reach the eGFR threshold for kidney failure, underscoring the prognostic significance of proteinuria in patients with advanced CKD.

C. Park, H. J. Hong, Hyungwoo Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.